Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02607553
Title Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors GenSpera, Inc.

clear cell renal cell carcinoma



Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.